Companies unite in shared vision of enabling researchers to translate genomic insights to groundbreaking discoveries Partnership includes launch of new IDT xGen™ NGS products designed exclusively for ...
Element has begun shipping AVITI to its first set of customers, comprised of major core labs and genome centers in the US, with some customers purchasing multiple units. “The commitments of these ...
SOUTH SAN FRANCISCO, Calif. & SAN DIEGO, October 06, 2025--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, and Element Biosciences, Inc., a ...
The AVITA as seen in an image from an Element Biosciences 3D demo. Photo credit: elementbiosciences.com/3d-virtual-demo San Diego’s Element Biosciences has ...
SAN DIEGO — Companies racing to read the genome accurately, quickly, and affordably have hit a snag recently, with several firms reporting that their growth has slowed, stalled, or reversed. Upstart ...
Element's groundbreaking sequencing is driving significant advancements in precision diagnostics research across critical disease areas," said Thomas P. Slavin, Chief Scientific Officer at HALO ...
Twist Bioscience and Element Biosciences have introduced the Trinity Freestyle Fast Hybridization workflow for Element’s AVITI™ sequencing platforms. The workflow enables sample to sequencing in as ...
Ongoing verification study supports compatibility of DeepChek® with the AVITI™ platform. Expands opportunities in infectious disease sequencing workflows. WOIPPY ...
Looking to be more upstart than startup, Element Biosciences has raised more than $277 million in new venture capital funding to help it take on the DNA sequencing giant located right down the road ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
SAN DIEGO, April 19, 2023 /PRNewswire/ -- Element Biosciences, Inc.— developer of an innovative DNA sequencing platform that is disrupting the genomics industry — has signed distribution agreements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results